Deterioration of Renal Function During Angiotensin Converting Enzyme Inhibition in Hypertensive Patients with a Poorly Functioning Solitary Kidney

REFERENCES

• Aurell, M., Delin, K. & Herlitz, H. 1982. Captopril in treatment-resistant essential and renal hypertension. Scand J Urol Nephrol 16, 243.
   PubMed Web of Science ®Google Scholar
• Aurell, M., Delin, K., Herlitz, H. & Mulec, H. 1982. Captopril treatment in hypertensive dialysis patients. Scand J Urol Nephrol 16, 251.
   PubMed Web of Science ®Google Scholar
• Bell, G. M., Watson, M. L., Doig, A., Muir, A. L. & Winney, R. J. 1982. Low dose Captopril in the treatment of severe refractory hypertension associated with renal failure. Postgrad Med J 58, 419.
   PubMed Web of Science ®Google Scholar
• Bengis, R. G. & Coleman, T. G. 1979. Antihypertensive effect of prolonged blockade of angiotensin formation in benign and malignant, one- and two-kidney Goldblatt hypertensive rats. Clin Sci 57, 53.
   PubMed Web of Science ®Google Scholar
• Bravo, E. L. & Tarazi, R. C. 1979. Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension 1, 39.
   PubMed Web of Science ®Google Scholar
• Brøchner-Mortensen, J. 1972. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30, 271.
   PubMed Web of Science ®Google Scholar
• Collste, P., Haglund, K., Lundgren, G., Magnusson, G. & Östman, J. 1979. Reversible renal failure during treatment with Captopril. Lancet ii, 612.
   Google Scholar
• Curtis, J. J., Luke, R. G., Whelchel, J. D., Diethelm, A. G., Jones, P. & Dustan, H. P. 1983. Inhibition of angiotensin converting enzyme in renal-transplant recipients with hypertension. N Engl J Med 308, 377.
   PubMed Web of Science ®Google Scholar
• Giese, J., Damkjær Nielsen, M. & Kappelgaard, A. M. 1981. Concentrations of active and inactive renin in human plasma: concepts and methodology. In Heterogeneity of renin and renin substrate (ed.M. P.Sambhi), pp. 205–213. Elsevier/North-Holland, Amsterdam.
   Google Scholar
• Grossman, A., Eckland, D., Prince, P. & Edwards, C. R. W. 1980. Captopril: Reversible renal failure with severe hyperkalaemia. Lancet i, 712.
   Google Scholar
• Hall, J. E., Coleman, T. G., Guyton, A. C., Balfe, J. W. & Salgado, H. C. 1979. Intrarenal role of angiotensin II and [des-Asp1]angiotensin II. Am J Physiol 236, F252.
   PubMedGoogle Scholar
• Havelka, J., Vetter, H., Studer, A., Greminger, P., Lüscher, T., Wollnik, S., Siegenthaler, W. & Vetter, W. 1982. Acute and chronic effects of the angiotensin-converting enzyme inhibitor Captopril in severe hypertension. Am J Cardiol 49, 1467.
   PubMed Web of Science ®Google Scholar
• Helmchen, U., Gröne, H. J., Kirchertz, E. J., Bader, H., Bohle, R. M., Kneissler, U. & Khosla, M. C. 1982. Contrasting renal effects of different antihypertensive agents in hypertensive rats with bilaterally constricted renal arteries. Kidney Int 22 (suppl. 12), S-198.
   PubMedGoogle Scholar
• Hollenberg, N. K., Meggs, L. G., Williams, G. H., Katz, J., Garnic, J. D. & Harrington, D. P. 1981. Sodium intake and renal responses to Captopril in normal man and in essential hypertension. Kidney Int 20, 240.
   PubMed Web of Science ®Google Scholar
• Hooke, D., Walker, R. G., Walter, N. M. A., D'Apice, A. J. F., Whitworth, J. A. & Kincaid-Smith, P. 1982. Repeated renal failure with use of Captopril in a cystinotic renal allograft recipient. Br Med J 285, 1538.
   PubMedGoogle Scholar
• Hricik, D. E., Browning, P. J., Kopelman, R., Goorno, W. E., Madias, N. E. & Dzau, V. 1983. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med 308, 373.
   PubMed Web of Science ®Google Scholar
• Huang, W.-C., Ploth, D. W., Bell, D., Work, J. & Navar, L. G. 1981. Bilateral renal function responses to converting enzyme inhibitor (SQ 20.881) in two-kidney, one clip Goldblatt hypertensive rats. Hypertension 3, 285.
   PubMed Web of Science ®Google Scholar
• Kappelgaard, A. M., Damkjær Nielsen, M. & Giese, J. 1976. Measurements of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta 67, 299.
   PubMed Web of Science ®Google Scholar
• Levens, R. L., Peach, M. J. & Carey, R. M. 1981. Role of the intrarenal renin–angiotensin system in the control of renal function. Circ Res 48, 157.
   PubMed Web of Science ®Google Scholar
• Lopez-Ovejero, J. A., Saal, S. D., D'Angelo, W. A., Cheigh, J. S., Stenzel, K. H. & Laragh, J. H. 1979. Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med 300, 1417.
   PubMed Web of Science ®Google Scholar
• Mason, J. C. & Hilton, P. J. 1983. Reversible renal failure due to Captopril in a patient with transplant artery stenosis. Hypertension 5, 623.
   PubMed Web of Science ®Google Scholar
• Navar, L. G., Jirakulsomchok, D., Bell, D., Thomas, C. D. & Huang, W.-C. 1982. Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs. Hypertension 4, 58.
   PubMed Web of Science ®Google Scholar
• Rasmussen, S., Brahm, M., Damkjær Nielsen, M., Giese, J., Larsen, S. & Brun, C. 1983. Postpartum renal failure and malignant hypertension treated with Captopril. Scand J Urol Nephrol 17, 209.
   PubMed Web of Science ®Google Scholar
• Silas, J. H., Klenka, Z., Solomon, S. A. & Bone, J. M. 1983. Captopril induced reversible renal failure: a marker of renal artery stenosis affecting a solitary kidney. Br Med J 286, 1702.
   PubMedGoogle Scholar
• Textor, S. C., Gephardt, G. N., Bravo, E. L., Tarazi, R. C., Fouad, F. M., Tubbs, R. & McMahon, J. T. 1983. Membranous glomerulopathy associated with Captopril therapy. Am J Med 74, 705.
   PubMed Web of Science ®Google Scholar
• Watson, M. L., Bell, G. M., Muir, A. L., Buist, T. A. S., Kellett, R. J. & Padfield, P. L. 1983. Captopril/diuretic combination in severe renovascular disease: a cautionary note. Lancet ii, 404.
   Google Scholar